<DOC>
	<DOC>NCT01846689</DOC>
	<brief_summary>The objective of this study is to measure the change in blood values after the administration of an amino acid based erythropoietin stimulating system.</brief_summary>
	<brief_title>An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic Disease</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>1. M/F patients 18 years old and over, nonpregnant/lactating 2. Hemoglobin &lt; 10 female,&lt;11 male 3. Ferritin &gt; upper limit of normal for lab indicative of chronic anemia 4. Anemia of chronic disease 5. Crt. &lt; 3.0 1. Currently taking other amino acid formulations. 2. Pregnant or unwilling to use adequate birth control for the duration of the study. 3. Excessive alcohol or illicit drug use. 4. Unwilling or unable to sign informed consent. 5. Myocardial infarction within the last 6 months. 6. Patients ever having taken or currently taking an erythropoietin medication. 7. Iron deficiency (add criteria). 8. On dialysis. 9. Malignancy other than nonmelanoma skin cancer within the last 5 years. If has such malignancy, must have documentation of no recurrence for at least 5 years. 10. Liver cirrhosis (add criteria).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2013</verification_date>
</DOC>